Intravenous vs intrathecal transplantation of allogeneic GMP/GCP compliant Wharton's jelly mesenchymal stromal cells in ALS patients: a phase I study.
- DOI
- 10.1080/17582024.2025.2553499
- Published
- 2025-08-29
- Container
- Neurodegener Dis Manag
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/17582024.2025.2553499,
title = {Intravenous vs intrathecal transplantation of allogeneic GMP/GCP compliant Wharton's jelly mesenchymal stromal cells in ALS patients: a phase I study.},
author = {Karimi S and Ghaheri A and Madani H and Beheshti Maal A and Sadri B and Khodadoust E and Sharafi F and Vosough M and Nabavi SM.},
year = {2026},
journal = {Neurodegener Dis Manag},
doi = {10.1080/17582024.2025.2553499},
url = {https://doi.org/10.1080/17582024.2025.2553499}
}RIS
TY - JOUR TI - Intravenous vs intrathecal transplantation of allogeneic GMP/GCP compliant Wharton's jelly mesenchymal stromal cells in ALS patients: a phase I study. AU - Karimi S AU - Ghaheri A AU - Madani H AU - Beheshti Maal A AU - Sadri B AU - Khodadoust E AU - Sharafi F AU - Vosough M AU - Nabavi SM. PY - 2026 JO - Neurodegener Dis Manag DO - 10.1080/17582024.2025.2553499 UR - https://doi.org/10.1080/17582024.2025.2553499 ER -
APA
S, K., A, G., H, M., A, B. M., B, S., E, K., F, S., M, V., & SM., N. (2026). Intravenous vs intrathecal transplantation of allogeneic GMP/GCP compliant Wharton's jelly mesenchymal stromal cells in ALS patients: a phase I study.. Neurodegener Dis Manag. https://doi.org/10.1080/17582024.2025.2553499
Source records
- europe-pmc · retrieved 2026-09-27T08:14:21.197Z